March 31, 2020
Lonza launches medium for gene therapy applications AAV production
Swiss-based Lonza has launched the TheraPEAK SfAAV Medium, the first chemically defined, non-animal origin medium designed specifically for the production of Adeno Associated Virus (AAV) in Spodoptera Fuigiperda (Sf9) insect cells for gene therapy applications.